首页|期刊导航|中药药理与临床|基于PI3K/AKT/HIF-1α通路探讨泄浊解毒方调控糖酵解改善肠黏膜屏障治疗溃疡性结肠炎的机制研究

基于PI3K/AKT/HIF-1α通路探讨泄浊解毒方调控糖酵解改善肠黏膜屏障治疗溃疡性结肠炎的机制研究OA

Exploring the Mechanism of Xiezhuo Jiedu Formula in Regulating Glycolysis to Improve Intestinal Mucosal Barrier in the Treatment of Ulcerative Colitis via the PI3K-AKT-HIF-1α Pathway

中文摘要英文摘要

目的:通过生物信息学、机器学习及动物实验探究泄浊解毒方调控糖酵解改善肠黏膜屏障治疗溃疡性结肠炎的作用机制.方法:通过基因综合表达数据库(GEO)提取 UC 基因芯片,并获得差异基因(DEGs),通过Genecards 数据库提取糖酵解(Glycolysis)基因集,通过韦恩图获取交集基因(Gly-DEGs),通过 Metascape 数据库进行 GO 和 KEGG 富集分析,通过支持向量机(SVM)、随机森林(RF)、受试者工作特征(ROC)机器学习筛选具备诊断及治疗潜能的核心 Gly-DEGs,通过反卷积法(CIBERSORT)进行免疫浸润分析.以 2,4,6-三硝基苯磺酸(TNBS)-无水乙醇诱导 UC 大鼠模型,取大鼠血液及结肠组织作为标本,苏木精-伊红(HE)染色观察大鼠结肠病理学形态;ELISA 法检测大鼠血清促炎因子白介素1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、IL-10 含量;免疫组化法检测大鼠结肠磷酸烯醇丙酮酸羧激酶 1(PCK1)、血小板内皮细胞粘附分子-1(PECAM1)、基质金属蛋白酶-1(MMP1)、乳酸脱氢酶 A(LDHA)、己糖激酶2(HK2)蛋白阳性表达水平;免疫荧光(IF)法检测大鼠结肠组织闭合蛋白(Occludin)、粘蛋白 2(MUC2)、连接黏附分子 A(JAM-A)表达水平;Real-time PCR 法检测大鼠结肠组织Pck1、Pecam1、Mmp1、Ldha、Hk2 mRNA 表达;Western blot 法检测大鼠结肠组织 PCK1、PECAM1、MMP1、PI3K、p-PI3K、AKT、p-AKT、HIF-1α 蛋白表达.结果:通过 GEO 数据库检索到 GSE206285、GSE87466 数据集,分别获得1 510、957 个差异基因,通过 Genecards 数据库得到 4 682 个糖酵解基因,通过交集得到 144 个 Gly-DEGs,KEGG结果表明,Gly-DEGs 主要富集于 IL-17、PI3K-AKT、PPAR、HIF-1 等信号通路,通过 SVM、RF、ROC 模型,最终得到3 个核心Gly-DEGs(PCK1、PECAM1、MMP1).免疫浸润分析结果表明,记忆B 细胞、浆细胞、CD8+T 细胞、自然杀伤细胞、M0、M1 型巨噬细胞、肥大细胞等存在显著差异(P<0.01),核心 Gly-DEGs 的表达与 T 细胞、巨噬细胞、树突状细胞、中性粒细胞等存在显著相关性,核心 Gly-DEGs 与肠黏膜屏障相关性分析结果表明,核心 Gly-DEGs 与OCLN(Occludin)、MUC2、F11R(JAM-A)存在显著的相关性(P<0.05).动物实验结果表明:与正常对照组比较,模型对照组结肠黏膜出现明显的病理改变,黏膜上皮完整性被破坏,溃疡形成,腺体结构紊乱、减少甚至消失,黏膜层及固有层见炎症细胞浸润,血清炎症因子 IL-1β、TNF-α 含量显著升高,IL-10 含量显著降低(P<0.01),结肠组织 MMP1、PECAM1、LDHA、HK2 阳性表达面积显著增加,蛋白及 mRNA 表达显著上调(P<0.01),Occludin、MUC2、JAM-A 免疫荧光强度显著降低(P<0.01),PI3K、p-PI3K、AKT、p-AKT、HIF-1α 蛋白表达显著上调(P<0.01),PCK1 呈阴性或弱阳性表达,蛋白及 mRNA 显著下调(P<0.01);与模型对照组比较,泄浊解毒方 6.7、13.3、26.6 g/kg 组可见结肠组织大部分上皮结构基本完整,腺体排列基本规则,仅有少量炎症细胞浸润,血清 IL-1β、TNF-α 含量显著降低,IL-10 含量显著增加(P<0.01),结肠组织 MMP1、PECAM1、LDHA、HK2 阳性表达面积显著降低、蛋白及 mRNA 表达显著下调(P<0.01),Occludin、MUC2、JAM-A 免疫荧光强度显著增加(P<0.01),PI3K、p-PI3K、AKT、p-AKT、HIF-1α 蛋白表达显著下调(P<0.01),PCK1 呈阳性表达,表达水平显著增加,蛋白及mRNA 显著上调(P<0.01).结论:PCK1、PECAM1、MMP1 是具有诊断及治疗潜能的核心 Gly-DEGs 标志物,介导T 细胞、巨噬细胞、树突状细胞、中性粒细胞等多种免疫细胞及肠上皮细胞代谢途径,泄浊解毒方可通过靶向PI3K-AKT-HIF-1α-糖酵解-肠黏膜屏障轴治疗 UC.

Objective:To investigate the mechanism of Xiezhuo Jiedu Formula(泄浊解毒方)in treating ulcerative colitis(UC)by regulating glycolysis to improve the intestinal mucosal barrier through bioinformatics,machine learning,and animal experiments.Methods:UC gene microarray data were extracted from the Gene Expression Omnibus(GEO)database to identify differentially expressed genes(DEGs).Glycolysis-related gene sets were retrieved from the Gene-Cards database.Intersecting genes(Gly-DEGs)were identified using a Venn diagram.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses were performed using the Metascape data-base.Core Gly-DEGs with diagnostic and therapeutic potential were screened through machine learning algorithms,inclu-ding Support Vector Machine(SVM),Random Forest(RF),and Receiver Operating Characteristic(ROC)analysis.Immune infiltration analysis was conducted using the CIBERSORT deconvolution method.A UC rat model was induced using 2,4,6-trinitrobenzenesulfonic acid(TNBS)-absolute ethanol.Blood and colon tissue samples were collected from the rats.Histopathological morphology of the colon was observed by hematoxylin-eosin(HE)staining.Serum levels of the pro-inflammatory cytokines interleukin-1β(IL-1β)and tumor necrosis factor-α(TNF-α),and interleukin-10(IL-10)were measured by enzyme-linked immunosorbent assay(ELISA).The expression levels of phosphoenolpyruvate car-boxykinase 1(PCK1),platelet endothelial cell adhesion molecule-1(PECAM1),matrix metalloproteinase-1(MMP1),lactate dehydrogenase A(LDHA),and hexokinase 2(HK2)in colon tissue were detected by immunohistochemistry(IHC).The expression levels of occludin,mucin 2(MUC2),and junctional adhesion molecule A(JAM-A)in colon tis-sue were detected by immunofluorescence(IF)assay.The mRNA expression levels of Pck1,Pecam1,Mmp1,Ldha,and Hk2 in colon tissue were quantified by real-time quantitative polymerase chain reaction(Real-time PCR).The protein expression levels of PCK1,PECAM1,MMP1,PI3K,phosphorylated PI3K(p-PI3K),AKT,phosphorylated AKT(p-AKT),and hypoxia-inducible factor-1α(HIF-1α)in colon tissue were determined by Western blot.Results:Through the GEO database,the datasets GSE206285 and GSE87466 were retrieved,yielding 1510 and 957 DEGs,respectively.A total of 4682 glycolysis-related genes were obtained from the GeneCards database,and by intersecting these,144 Gly-DEGs were identified.KEGG pathway enrichment analysis revealed that these Gly-DEGs were mainly enriched in the IL-17,PI3K-Akt,PPAR,and HIF-1 signaling pathways.Using SVM,RF,and ROC models,three core Gly-DEGs(PCK1,PECAM1,MMP1)were ultimately identified.Immune infiltration analysis demonstrated significant differences in memory B cells,plasma cells,CD8+T cells,natural killer cells,M0 macrophages,M1 macrophages,and mast cells(P<0.01).The expression of the core Gly-DEGs showed significant correlations with T cells,macrophages,dendritic cells,and neu-trophils.Correlation analysis between the core Gly-DEGs and intestinal mucosal barrier markers indicated significant cor-relations with occludin,MUC2,and F11R(JAM-A)(P<0.05).Animal experiment results indicated that compared with the normal control group,the model control group showed significant pathological changes in the colonic mucosa,inclu-ding disrupted epithelial integrity,ulcer formation,disorganized,reduced,or absent glandular structures,and inflammatory cell infiltration in the mucosal layer and lamina propria.Serum levels of the inflammatory factors IL-1β and TNF-α sig-nificantly increased,while the IL-10 level significantly decreased.The positive expression areas of MMP1,PECAM1,LDHA,and HK2 in colon tissue significantly increased,while protein and mRNA expressions were significantly upregulat-ed(P<0.01).The immunofluorescence intensity of occludin,MUC2,and F11R(JAM-A)significantly decreased(P<0.01),and the protein expression levels of PI3K,p-PI3K,AKT,p-AKT,and HIF-1α were significantly upregulated(P<0.01).PCK1 expression was negative or weakly positive,while its protein and mRNA expression were significantly downregulated(P<0.01).Compared with the model control group,the Xiezhuo Jiedu Formula groups showed largely in-tact epithelial structures,basically regular gland arrangement,and only a small amount of inflammatory cell infiltration.The serum IL-1β and TNF-α levels significantly decreased,while the IL-10 level significantly increased.The positive ex-pression areas of MMP1,PECAM1,LDHA,and HK2 in colon tissue were significantly reduced,with their protein and mRNA expression levels significantly downregulated(P<0.01).The immunofluorescence intensity of occludin,MUC2,and F11R(JAM-A)significantly increased(P<0.01).The protein expression levels of PI3K,p-PI3K,AKT,p-AKT,and HIF-1α were significantly downregulated(P<0.01).PCK1 expression was positive and significantly increased,and its protein and mRNA expression levels were significantly upregulated(P<0.01).Conclusion:PCK1,PECAM1,and MMP1 are core Gly-DEGs markers with diagnostic and therapeutic potential,mediating metabolic pathways involving vari-ous immune cells,such as T cells,macrophages,dendritic cells,neutrophils,as well as intestinal epithelial cells.Xiezhuo Jiedu Formula can treat UC by targeting the PI3K-AKT-HIF-1α-glycolysis-intestinal mucosal barrier axis.

揣强;任士杰;蒋晓红;刘欣;郎晓猛;郭佳;刘建平;赵源

河北中医药大学研究生学院,石家庄 050091||河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北中医药大学研究生学院,石家庄 050091||河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北中医药大学研究生学院,石家庄 050091||河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北中医药大学研究生学院,石家庄 050091||河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北中医药大学研究生学院,石家庄 050091||河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013河北省中医院,石家庄 050013||河北省中西医结合胃肠病研究重点实验室,石家庄 050013||河北省浊毒证重点实验室,石家庄 050013

泄浊解毒方糖酵解生物信息学溃疡性结肠炎磷脂酰肌醇3-激酶蛋白激酶低氧诱导因子-1α

Xiezhuo Jiedu FormulaGlycolysisBioinformaticsUlcerative colitisPhosphatidylinositol 3-kinase(PI3K)Protein kinase B(AKT)Hypoxia-inducible factor 1-α(HIF-1α)

《中药药理与临床》 2026 (7)

34-47,14

国家中医临床研究基地建设项目(国中医药办科技函[2018]18)河北省中西医结合胃肠病研究重点实验室(编号:SZX2021019)河北省中医药管理局科研计划项目(编号:2025008)河北省自然科学基金项目(编号:H2022423326).

评论